- Report
- January 2022
- 200 Pages
Global
From €7252EUR$7,500USD£6,187GBP
- Report
- April 2024
- 115 Pages
From €4351EUR$4,500USD£3,712GBP
- Report
- August 2022
- 120 Pages
Global
From €4351EUR$4,500USD£3,712GBP
- Report
- November 2018
- 30 Pages
China
From €2127EUR$2,200USD£1,815GBP
- Report
- February 2018
- 680 Pages
Global
From €21272EUR$22,000USD£18,149GBP
- Report
- May 2022
- 120 Pages
Global
From €2417EUR$2,500USD£2,062GBP
- Report
- April 2023
- 116 Pages
Global
From €4351EUR$4,500USD£3,712GBP
- Report
- August 2022
United States
From €1876EUR$1,940USD£1,600GBP
- Report
- August 2022
Global
From €1151EUR$1,190USD£982GBP
- Report
- August 2021
Europe
From €3307EUR$3,420USD£2,821GBP
- Report
- August 2021
Global
From €3858EUR$3,990USD£3,292GBP
- Report
- February 2021
Global
From €2862EUR$2,960USD£2,442GBP
- Report
- October 2022
- 81 Pages
Global
From €3379EUR$3,495USD£2,883GBP
- Report
- November 2020
- 36 Pages
Global
From €3863EUR$3,995USD£3,296GBP
- Drug Pipelines
- October 2020
- 811 Pages
Global
From €1934EUR$2,000USD£1,650GBP
- Report
- July 2023
- 133 Pages
China
From €1740EUR$1,800USD£1,485GBP
- Report
- July 2023
- 101 Pages
China
From €1740EUR$1,800USD£1,485GBP
- Report
- April 2023
- 109 Pages
Global
€3384EUR$3,500USD£2,887GBP
- Report
- March 2024
- 90 Pages
Global
From €3500EUR$3,878USD£3,091GBP
- Report
- January 2024
- 105 Pages
Global
From €3500EUR$3,878USD£3,091GBP
The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more